[HTML] cell.com

[HTML][HTML] Design of a stabilized RBD enables potently neutralizing SARS-CoV-2 single-component nanoparticle vaccines

TH Dickey, R Ma, S Orr-Gonzalez, T Ouahes, P Patel… - Cell reports, 2023 - cell.com
Waning immunity and emerging variants necessitate continued vaccination against severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Improvements in vaccine safety …
被引用次数：10 相关文章
[HTML] sciencedirect.com

[HTML][HTML] Design of a stabilized RBD enables potently neutralizing SARS-CoV-2 single-component nanoparticle vaccines

TH Dickey, R Ma, S Orr-Gonzalez, T Ouahes, P Patel… - Cell Reports, 2023 - Elsevier
Waning immunity and emerging variants necessitate continued vaccination against severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Improvements in vaccine safety …

Design of a stabilized RBD enables potently neutralizing SARS-CoV-2 single-component nanoparticle vaccines

TH Dickey, R Ma, S Orr-Gonzalez, T Ouahes… - Cell …, 2023 - pubmed.ncbi.nlm.nih.gov
Waning immunity and emerging variants necessitate continued vaccination against severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Improvements in vaccine safety …

Design of a stabilized RBD enables potently neutralizing SARS-CoV-2 single-component nanoparticle vaccines.

TH Dickey, R Ma, S Orr-Gonzalez, T Ouahes, P Patel… - Cell Reports, 2023 - europepmc.org
Waning immunity and emerging variants necessitate continued vaccination against severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Improvements in vaccine safety …
[HTML] nih.gov

[HTML][HTML] Design of a stabilized RBD enables potently neutralizing SARS-CoV-2 single-component nanoparticle vaccines

TH Dickey, R Ma, S Orr-Gonzalez, T Ouahes, P Patel… - Cell Reports, 2023 - ncbi.nlm.nih.gov
Waning immunity and emerging variants necessitate continued vaccination against severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Improvements in vaccine safety …

Design of a stabilized RBD enables potently neutralizing SARS-CoV-2 single-component nanoparticle vaccines

T Dickey, R Ma, S Orr-Gonzalez, T Ouahes, P Patel… - Cell Reports, 2023 - europepmc.org
Waning immunity and emerging variants necessitate continued vaccination against SARS-
CoV-2. Improvements in vaccine safety, tolerability, and ease of manufacturing would benefit …